Fortress Private Ledger’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$327K Buy
658
+195
+42% +$86.4K 0.09% 205
2026
Q1
$207K Buy
+463
New +$216K 0.06% 235
2025
Q2
Sell
-507
Closed -$246K 197
2025
Q1
$246K Buy
+507
New +$236K 0.14% 144

Other funds holding VRTX

Fortress Private Ledger's VRTX Position: Q2 2026 in Review

Fortress Private Ledger increased its Vertex Pharmaceuticals (VRTX) stake by 42% in Q2 2026, buying an estimated $86.4K and bringing the position to 658 shares worth $327K. The position accounts for 0.09% of the portfolio, ranked #205.

Fortress Private Ledger first reported a position in VRTX in Q1 2025 and has held it in 3 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Fortress Private Ledger held 658 shares of Vertex Pharmaceuticals worth $327K as of Q2 2026.
  • Fortress Private Ledger bought 195 Vertex Pharmaceuticals shares in Q2 2026, an estimated $86.4K.
  • Vertex Pharmaceuticals made up 0.09% of Fortress Private Ledger's portfolio in Q2 2026, its #205 holding.
  • Fortress Private Ledger first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Fortress Private Ledger's 13F filing for Q2 2026, filed 7 Aug 2026.